Drug Trial Radar · NCT06978699
A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
May 21, 2025
Primary completion
Jan 21, 2026
Study completion Jan 21, 2026
Sponsor
- Lead sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, single-blind Phase II trial to evaluate the efficacy and safety of XH-S003 capsules in PNH patients. About 24 PNH patients will be enrolled and randomized to three dose levels and take XH-S003 capsules orally according to protocol.
Conditions
- PNH - Paroxysmal Nocturnal Hemoglobinuria
Interventions
XH-S003 CapsuleDrug
XH-S003 Capsule, Administered orally once daily, 125mg
XH-S003 CapsuleDrug
XH-S003 Capsule, Administered orally once daily, 100mg
XH-S003 CapsuleDrug
XH-S003 Capsule, Administered orally once daily, 50mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes of hemoglobin compared with baselineTime frame: 12 weeks from baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
TianJin Medical University General Hospital
Tianjin, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.